Funding Rounds
Acesion Pharma

Acesion Pharma Series B (2023, $47M)

Acesion Pharma

Therapy to treat atrial fibrillation (AF).

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $47.59M

Investors